Joachim C. Mertens

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 284 citations · Full text

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index

Jacqueline Bachofner, Piero V. Valli, Arne Kröger et al. · Liver International · 2016 · 275 citations

Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.

Wen Xie, Joachim C. Mertens, Daniel Reiss et al. · PubMed · 2002 · 217 citations

Breast Oncology, Poor Outcome, Pathology +17

Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma

Joachim C. Mertens, Christian D. Fingas, John D. Christensen et al. · Cancer Research · 2012 · 205 citations · Full text